3CE Fitting Cushion Foundation 001

Product NDC
60764-131
11-digit product format
607640131
Labeler code
60764
Product ID
60764-131_418e77e4-0c9a-4f59-9043-4b4840891ddc
Type
HUMAN OTC DRUG
Nonproprietary name
Titanium Dioxide, Octinoxate, Octisalate
Dosage form
POWDER
Route
TOPICAL
Labeler
Nanda Co., Ltd
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2016-08-10
Marketing end
0000-00-00
Substance
TITANIUM DIOXIDE; OCTINOXATE; OCTISALATE
Active strength
2 g/12g; g/12g; g/12g
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60764-131-022020-01-31C16284748780-19d75b9d0-b9c8-f424-e053-dadaa90a57ce1fca9d20-6a3c-40c8-8978-de46c5eb85fc

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60764-131-013CE Fitting Cushion Foundation 00112 g in 1 CONTAINERPOWDER121
60764-131-023CE Fitting Cushion Foundation 0012 in 1 CARTONPOWDER21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60764-1313CE FITTING CUSHION FOUNDATION 001 (TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE) POWDER [NANDA CO., LTD]1Legacy NDC, 2 package rows20161017_1fca9d20-6a3c-40c8-8978-de46c5eb85fc.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
60764-131-016076401310112 g in 1 CONTAINER12 gHistorical
60764-131-02607640131022 in 1 CARTONHistorical